{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:23:56Z","timestamp":1793165036660,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273991"],"award-info":[{"award-number":["81273991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2019XZZX004-16"],"award-info":[{"award-number":["2019XZZX004-16"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.biopha.2020.109963","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T02:06:28Z","timestamp":1581041188000},"page":"109963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["MiR-30c-5p mediates the effects of panax notoginseng saponins in myocardial ischemia reperfusion injury by inhibiting oxidative stress-induced cell damage"],"prefix":"10.1016","volume":"125","author":[{"given":"Linli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.109963_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","article-title":"Acute myocardial infarction","volume":"389","author":"Reed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2020.109963_bib0010","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.109963_bib0015","series-title":"Myocardial Reperfusion Injury As a New Frontier for Clinical Therapy","author":"Hausenloy","year":"2012"},{"key":"10.1016\/j.biopha.2020.109963_bib0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J Clin Inves."},{"key":"10.1016\/j.biopha.2020.109963_bib0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biopha.2020.109963_bib0030","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S1474-4422(16)30246-0","article-title":"MicroRNAs in epilepsy: pathophysiology and clinical utility","volume":"15","author":"Henshall","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2020.109963_bib0035","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.109963_bib0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/apha.12416","article-title":"Application of microRNAs in diagnosis and treatment of cardiovascular disease","volume":"213","author":"Wronska","year":"2015","journal-title":"Acta Physiol."},{"key":"10.1016\/j.biopha.2020.109963_bib0045","doi-asserted-by":"crossref","first-page":"86926","DOI":"10.18632\/oncotarget.13494","article-title":"MicroRNA-214 protects against hypoxia\/reoxygenation induced cell damage and myocardial ischemia\/reperfusion injury via suppression of PTEN and Bim1 expression","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2020.109963_bib0050","first-page":"4614","article-title":"Cardiac myocyte-protective effect of microRNA-22 during ischemia and reperfusion through disrupting the caveolin-3\/eNOS signaling","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2020.109963_bib0055","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1159\/000366312","article-title":"By targeting Stat3 microRNA-17-5p promotes cardiomyocyte apoptosis in response to ischemia followed by reperfusion","volume":"34","author":"Du","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2020.109963_bib0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/cvr\/cvq053","article-title":"Downregulation of microRNA-29 by antisense inhibitors and a PPAR-\u03b3 agonist protects against myocardial ischaemia\u2013reperfusion injury","volume":"87","author":"Zhang","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2020.109963_bib0065","article-title":"Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.109963_bib0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.amjcard.2004.03.021","article-title":"Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction","volume":"94","author":"Claeys","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2020.109963_bib0075","first-page":"45","article-title":"Effect of XueSaiTong Injecta on thrombocytic activation in CAD patients","volume":"1","author":"Xiao-lin","year":"2010","journal-title":"Strait Pharmaceutical J."},{"key":"10.1016\/j.biopha.2020.109963_bib0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12906-015-0560-4","article-title":"Xuesaitong injection as one adjuvant treatment of acute cerebral infarction: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2020.109963_bib0085","first-page":"348","article-title":"Effect of intracoronary injection with xuesaitong in treating post-PCI slow-reflow phenomenon in patients with ST-segment elevation myocardial infarction","volume":"30","author":"Gan","year":"2010","journal-title":"Chin. J. Integr. Tradit. West Med."},{"key":"10.1016\/j.biopha.2020.109963_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchromb.2016.01.039","article-title":"Integrating candidate metabolites and biochemical factors to elucidate the action mechanism of Xue-sai-tong injection based on (1)H NMR metabolomics","volume":"1026","author":"Jiang","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.biopha.2020.109963_bib0095","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1039\/C7MB00140A","article-title":"Proteomic analysis reveals Xuesaitong injection attenuates myocardial ischemia\/reperfusion injury by elevating pyruvate dehydrogenase-mediated aerobic metabolism","volume":"13","author":"Zhao","year":"2017","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.biopha.2020.109963_bib0100","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"MiRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.109963_bib0105","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.109963_bib0110","doi-asserted-by":"crossref","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","article-title":"miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions","volume":"46","author":"Chou","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.109963_bib0115","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1039\/C3MB70581A","article-title":"Dissecting active ingredients of Chinese medicine by content-weighted ingredient-target network","volume":"10","author":"Wang","year":"2014","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.biopha.2020.109963_bib0120","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41419-018-0805-5","article-title":"MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2020.109963_bib0125","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"van Rooij","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.109963_bib0130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/cvr\/cvv121","article-title":"MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death","volume":"106","author":"Tang","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2020.109963_bib0135","first-page":"139","article-title":"Inhibition of MicroRNA-29b protects H9C2 cardiomyocytes from Hypoxia\/Reoxygenation-Induced apoptosis","volume":"38","author":"Zhu","year":"2016","journal-title":"Anal. Quant. Cytopathol."},{"key":"10.1016\/j.biopha.2020.109963_bib0140","first-page":"3677","article-title":"FGF21 protects myocardial ischemia-reperfusion injury through reduction of miR-145-mediated autophagy","volume":"10","author":"Hu","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2020.109963_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28323","article-title":"Role of microRNA-145 in protection against myocardial ischemia\/reperfusion injury in mice by regulating expression of GZMK with the treatment of sevoflurane","author":"Qi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2020.109963_bib0150","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"Zhao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.109963_bib0155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11010-016-2729-7","article-title":"miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy","volume":"417","author":"Raut","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2020.109963_bib0160","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor implications for a role of MicroRNAs in myocardial matrix remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2020.109963_bib0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1755-5922.12113","article-title":"miR-30c mediates upregulation of Cdc42 and Pak1 in diabetic cardiomyopathy","volume":"33","author":"Raut","year":"2015","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.biopha.2020.109963_bib0170","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1182\/blood-2012-04-423004","article-title":"The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis","volume":"120","author":"Bridge","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2020.109963_bib0175","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/cvr\/cvx157","article-title":"miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways","volume":"113","author":"Giannella","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2020.109963_bib0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1479-5876-11-154","article-title":"The altered expression profile of microRNAs in cardiopulmonary bypass canine models and the effects of mir-499 on myocardial ischemic reperfusion injury","volume":"11","author":"Qin","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2020.109963_bib0185","doi-asserted-by":"crossref","first-page":"H1908","DOI":"10.1152\/ajpheart.00250.2010","article-title":"p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress","volume":"299","author":"Kimata","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2020.109963_bib0190","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1092734","article-title":"Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis","volume":"303","author":"Chipuk","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.109963_bib0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1535-6108(03)00244-7","article-title":"Puma is an essential mediator of p53-dependent and -independent apoptotic pathways","volume":"4","author":"Jeffers","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2020.109963_bib0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/bbrc.2001.4927","article-title":"Reactive oxygen species up-regulates Cyclooxygenase-2, p53, and Bax mRNA expression in bovine luteal cells","volume":"284","author":"Nakamura","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2020.109963_bib0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/38525","article-title":"A model for p53-induced apoptosis","volume":"389","author":"Polyak","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.109963_bib0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.coph.2003.10.010","article-title":"Oxidative stress-elicited myocardial apoptosis during reperfusion","volume":"4","author":"Zhao","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biopha.2020.109963_bib0215","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejps.2009.08.008","article-title":"Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis","volume":"38","author":"Chan","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2020.109963_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2016.12.036","article-title":"miR-29c is implicated in the cardioprotective activity of Panax notoginseng saponins against isoproterenol-induced myocardial fibrogenesis","volume":"198","author":"Liu","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2020.109963_bib0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bcp.2013.05.006","article-title":"MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2","volume":"86","author":"Chan","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2020.109963_bib0230","article-title":"Ginsenoside Rd attenuates myocardial ischemia\/reperfusion injury via Akt\/GSK-3beta signaling and inhibition of the mitochondria-dependent apoptotic pathway","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.109963_bib0235","first-page":"14497","article-title":"Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2\/HO-1 signaling pathway","volume":"8","author":"Zeng","year":"2015","journal-title":"Int. J. Clin. Exp. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:48:20Z","timestamp":1790606900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220301530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":47,"alternative-id":["S0753332220301530"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109963","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-30c-5p mediates the effects of panax notoginseng saponins in myocardial ischemia reperfusion injury by inhibiting oxidative stress-induced cell damage","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109963"}}